![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 39/145 | (2006.01) |
A61K 35/74 | (2015.01) | ||
A61K 35/76 | (2015.01) | ||
A61K 39/00 | (2006.01) | ||
A61K 47/26 | (2006.01) | ||
A61K 47/38 | (2006.01) | ||
A61P 31/04 | (2006.01) | ||
A61P 31/12 | (2006.01) | ||
A61P 31/16 | (2006.01) | ||
A61K 9/19 | (2006.01) | ||
A61K 39/05 | (2006.01) | ||
A61K 39/08 | (2006.01) |
(11) | Patento numeris | 2689785 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13189570.8 |
Europos patento paraiškos padavimo data | 2011-04-15 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-01-29 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-19 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
324542 P | 2010-04-15 | US |
(72) |
NAGATA, Ryoichi, JP
HARUTA, Shunji, JP
|
(73) |
Shin Nippon Biomedical Laboratories, Ltd.,
2438, Miyanoura-cho Kagoshima-shi, Kagoshima 891-1394,
JP
KM Biologics Co., Ltd., 1-6-1 Okubo, Kita-ku, Kumamoto-shi,, Kumamoto 860-8568, JP |
(54) | Method for generating dry vaccine powder formulation for inranasal delivery |
Method for generating dry vaccine powder formulation for inranasal delivery |